Speech-Language Pathologists in Santa Fe, NM Accepting Medicare
86 Speech-Language Pathologists found. Showing 81 - 86
 Ms. Melissa Christine Wilson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Calle Medico, 681 Callecita Jicarilla, Santa Fe, NM 87505 Phone: 505-424-8777 Fax: 505-424-9777 |
Dana Sperry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Calle Medico, Santa Fe, NM 87505 Phone: 505-424-8777 |
 Shunjiro Clifford Kida Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Avenida De Las Campanas, Santa Fe, NM 87507 Phone: 505-467-1800 |
Mrs. Michelle Elizabeth Garcia, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1012 Marquez Pl, Suite 211, Santa Fe, NM 87505 Phone: 505-302-0095 |
Richard E Gonzales, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1300 Camino Sierra Vis, Santa Fe, NM 87505 Phone: 505-577-2992 Fax: 505-467-2648 |
Ms. Andrea Michelle Wennersten, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1450 Encina Rd, Santa Fe, NM 87505 Phone: 505-983-6829 |
News Archive
Study to evaluate vitaminD3, omega3 and home exercise in preventing age-related chronic diseases
In Europe, the number of seniors aged 70 and over will increase by 40% in the next 20 years, while those aged 80 and over will more than double. Health authorities and the medical community expect a corresponding increase in the number of people suffering costly and debilitating age-related chronic diseases such as osteoporosis, arthritis, heart and lung diseases and dementia.
Winners of PDA's 2015 National Children's Dental Health Month statewide poster contest announced
Third-grader Davida Brannigan of Solomon Plains Elementary in Luzerne County will receive a $500 prize for winning first place in the Pennsylvania Dental Association's 2015 National Children's Dental Health Month (NCDHM) statewide poster contest.
Mirror Effect of Immunovative Therapies: A new approach to cancer treatment
Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd, a biotech company in Israel, describes a new and unique approach to cancer treatment.
Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 5 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Optometrists
Podiatrists
Audiologists